Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: A robust method for vaccine design

FEBS Letters

Volumn 540, Issue 1-3, 2003, Pages 133-140

  Haro, Isabel ^a   Pérez, Silvia ^a   García, Mónica ^a   Chan, Weng C ^b   Ercilla, Guadalupe ^c  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Enzyme linked immunosorbent assay; Hepatitis A virus; Liposome; Multiple antigenic peptide; Peptide synthesis; Surface plasmon resonance

Indexed keywords

ANTISERUM; ENZYME; FREUND ADJUVANT; LIPOSOME; M PROTEIN; MULTIPLE ANTIGENIC PEPTIDE; PEPTIDE DERIVATIVE; PROTEIN VP1; PROTEIN VP3; TETRAMER; UNCLASSIFIED DRUG; VACCINE;

AMINO ACID SEQUENCE; ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DESIGN; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HEPATITIS A VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LIPOPHILICITY; MEASUREMENT; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN POLYMORPHISM; PROTEIN TARGETING; RABBIT; SURFACE PLASMON RESONANCE;

HEPATITIS A VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 0345270039     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00249-7     Document Type: Article

References (34)

1. Tam J.P. Proc. Natl. Acad. Sci. USA. 85:1988;5409-5413.
2. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Nussenzweig R.S. Adv. Immunol. 60:1995;105-149.
3. Haro I., Pinto R.M., González-Dankaart J.F., Pérez J.A., Reig F., Bosch A. Microbiol. Immunol. 39:1995;485-490.
4. Bosch A., González-Dankaart J.F., Haro I., Gajardo R., Pérez J.A., Pinto R.M. J. Med. Virol. 54:1998;95-102.
5. Pinto R.M., González-Dankaart J.F., Sánchez G., Guix S., Gómara M.J., García M., Haro I., Bosch A. FEBS Lett. 438:1998;106-110.
6. Firsova, T.V., Pérez, J.A., Reig, F., Kruglov, I.V. and Haro, I. (1996) in: Peptides 1996 (Ramage, R. and Epton, R., Eds.), pp. 383-384, Mayflower Science, UK.
7. Gómara M.J., Riedemann S., Vega I., Ibarra H., Ercilla G., Haro I. J. Immunol. Methods. 234:2000;23-24.
8. Gómara M.J., Ercilla G., Alsina M.A., Haro I. J. Immunol. Methods. 246:2000;13-24.
9. Hopp T.P. Mol. Immunol. 1:1984;13-16.
10. Uhl B., Wolf B., Scwinde A., Jung G., Bessler W.G., Hauschildt S. J. Leukoc. Biol. 50:1991;10-18.
11. Wolf B., Uhl B., Hauschild S., Metzger J., Bessler W.G. Immunobiology. 180:1989;93-100.
12. Tam P.J., Clavijo P., Lu Y.-A., Nussenzweig V., Nussenzweig R., Zavala V. J. Exp. Med. 171:1990;299-306.
13. Nardelli B., Lu Y.-A., Defoort-Delpierre C., Shiu D., Profy A.T., Tam J.P. J. Immunol. 148:1992;914-920.
14. McLean G., Cross A., Munns M., Marsden H.S. J. Immunol. Methods. 155:1992;113-120.
15. Chan, W.C. and White, P.D. (Eds.) (2000) Fmoc Solid Phase Peptide Synthesis: A Practical Approach, Oxford University Press, Oxford.
16. Bycroft, B.W., Chan, W.C., Chhabra, S.R. and Hone, N.D. (1993) J. Chem. Soc. Chem. Commun. 778-779.
17. García M., Alsina M.A., Reig F., Haro I. Vaccine. 18:2000;276-283.
18. McClare C.W. Anal. Biochem. 39:1971;527-530.
19. Beatty J.D., Beatty B.G., Vlahos W.G. J. Immunol. Methods. 100:1987;173-179.
20. Steward, M.W. and Steensgaard, J. (1983) Antibody Affinity: Thermodynamic Aspects and Biological Significance, CRC Press, Boca Raton, FL.
21. Van Cott T.C., Bethke F.R., Polonis V.R., Gorny M.K., Zollapazner S., Redfield R.R., Birx D.L. J. Immunol. 153:1994;449-459.
22. Christodoulides M., Rattue E., Heckels J.E. Vaccine. 18:2000;131-139.
23. Garcia M., Pujol M., Reig F., Alsina M.A., Haro I. Analyst. 121:1996;1583-1588.
24. Alving C.R. J. Immunol. Methods. 140:1991;1-13.
25. Deprez B., Sauzet J.P., Boutillon C., Martinon F., Tartar A., Sergheraert C., Guillet J.G., Gomard E., Gras-Masse H. Vaccine. 14:1996;375-382.
26. Benmohamed L., Thomas A., Bossus M., Brahimi K., Wubben J., Gras-Masse H., Druilhe P. Vaccine. 18:2000;2843-2855.
27. Nardelli B., Defoort J.P., Huang W., Tam J.P. Res. Hum. Retroviruses. 8:1992;1405-1407.
28. Van Rooijen, N. and Su, D. (1989) in: Immunological Adjuvants and Vaccines (Gregoriadis, G., Allsion, A.C. and Poste, G., Eds.), p. 95, Plenum Press, New York.
29. Steward M.W., Lew A.M. J. Immunol. Methods. 78:1985;173-176.
30. Tam J.P., Zavala F. J. Immunol. Methods. 124:1989;53-61.
31. Friguet B., Chaffotte A.F., Djavadi-Ohaniance L., Goldberg M.E. J. Immunol. Methods. 77:1985;305-319.
32. Pullen G.R., Fitzgerald M.G., Hosking C.S. J. Immunol. Methods. 86:1986;83-90.
33. Altschuh D., Dubs M.C., Weiss E., Zeder-Lutz G., van Regenmortel M.H.V. Biochemistry. 31:1982;6298-6304.
34. Malmqvist M. Nature. 361:1993;186-187.